# Task1878-1885 Desk-Specific Policy Replay

## Decision Summary

- Verdict: `desk_specific_policy_replay_complete_target_not_met`.
- Best policy: `desk_specific_top3_v1`.
- Best final equity: 3204.0915.
- Best CAGR: 0.253109.
- Best MDD: -0.240886.
- Strategy acceptance status: `NOT_ACCEPTED`.
- Deployment readiness: `DIAGNOSTIC_ONLY_NOT_DEPLOYMENT_READY`.
- Real capital: `FORBIDDEN`.

## Quant Expert Report

Implementation summary:

- SEC financing was repaired from broad `active_financing_pressure` into `live_active_dilution`, `shelf_capacity_watch`, `historical_or_closed_financing`, `boilerplate_or_sparse`, and `source_gap_neutral`.
- Winner desk gained a thesis-intact override using quality beta, sleeve quality, payoff score, volatility cause, expectation, absorption, SEC specificity, and theme breadth.
- Theme breadth was attached from existing pre-entry relative-return fields only.
- Speculative no-entry now requires source-specific `live_active_dilution`.
- Earnings revision remains vendor-blocked and has no assignment effect.
- Replay return source is the prior controlled winner-defense trade set; no new price matching was introduced.

Leakage audit:

- Assignment uses only source states known as-of.
- PnL, drawdown, net return, and future outcomes are audit-only.
- Missing raw source remains source gap, not negative evidence.

| Policy | Final | CAGR | MDD | Source-Attached Final | Delta vs Source | Base Final | Delta vs Base | Trades | Joint Target |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| `desk_specific_top3_v1` | 3204.0915 | 0.253109 | -0.240886 | 3097.4162 | 106.6753 | 3944.5457 | -740.4542 | 156 | 0 |
| `desk_specific_top5_v1` | 2476.2303 | 0.192075 | -0.176857 | 2286.7813 | 189.449 | 2822.4123 | -346.182 | 206 | 0 |

Split/OOS metrics:

| Policy | Window | Final | Return | MDD |
| --- | --- | ---: | ---: | ---: |
| `desk_specific_top3_v1` | IS_2021_2023 | 1663.9705 | 0.66397 | -0.240886 |
| `desk_specific_top3_v1` | OOS_2024_2026Q1 | 3204.0915 | 2.204092 | -0.15803 |
| `desk_specific_top5_v1` | IS_2021_2023 | 1500.655 | 0.500655 | -0.176857 |
| `desk_specific_top5_v1` | OOS_2024_2026Q1 | 2476.2303 | 1.47623 | -0.106281 |

Cost/slippage stress:

| Policy | Cost bps | Stressed Final | Beats QQQ |
| --- | ---: | ---: | ---: |
| `desk_specific_top3_v1` | 0 | 3204.0915 | 1 |
| `desk_specific_top3_v1` | 25 | 2766.733 | 1 |
| `desk_specific_top3_v1` | 50 | 2329.3745 | 1 |
| `desk_specific_top3_v1` | 100 | 1454.6575 | 0 |
| `desk_specific_top5_v1` | 0 | 2476.2303 | 1 |
| `desk_specific_top5_v1` | 25 | 2029.8898 | 1 |
| `desk_specific_top5_v1` | 50 | 1583.5493 | 0 |
| `desk_specific_top5_v1` | 100 | 690.8683 | 0 |

## No-Background Decision-Maker Report

1. The previous brain cut winners too broadly.
2. This task made the action desk-specific.
3. SEC danger now means live/current dilution, not any financing mention.
4. Strong winners can now hold through macro volatility if the thesis is intact.
5. The replay is still diagnostic only, not accepted for live capital.

## Artifact Manifest

- `task1878_input_manifest.csv`
- `task1878_sec_financing_specificity_panel.csv`
- `task1879_winner_thesis_override_panel.csv`
- `task1880_theme_breadth_panel.csv`
- `task1881_l3_desk_relation_edges.csv`
- `task1882_speculative_live_financing_block.csv`
- `task1883_defensive_buffer_validation_panel.csv`
- `task1884_l4_desk_thesis_cards.csv`
- `task1884_l5_desk_specific_budget.csv`
- `task1884_frozen_policy_config.csv`
- `task1885_controlled_desk_replay_trades.csv/equity`
- `task1885_desk_replay_metrics.csv/split_oos/cost_stress`
- `task1885_failure_attribution.csv`
- `task1885_acceptance_gate.csv`
- `task1885_closeout.csv/json`

Validation commands:

- `python scripts/trader_brain_1878_1885_desk_specific_policy_replay_validate.py`
- `python scripts/task_registry_validate.py`

```text
Test results do not modify strategy acceptance status.
Strategy: NOT_ACCEPTED
Deployment: DIAGNOSTIC_ONLY_NOT_DEPLOYMENT_READY
Real Capital: FORBIDDEN
```